Publications & Posters

Check out the latest posters and publications.


April 8, 2022 | From Theseus Pharmaceuticals

Discovery of potent and selective next-generation EGFR inhibitors with activity against single, double, and triple mutant EGFR variants including T790M and C797S

February 25, 2022 | From External Experts

New treatment strategies for advanced-stage gastrointestinal stromal tumours

April 15, 2021 | From External Experts

Overcoming therapy resistance in EGFR-mutant lung cancer

April 10, 2021 | From Theseus Pharmaceuticals

Preclinical characterization of THE-630, a next-generation inhibitor for KIT-mutant gastrointestinal stromal tumors (GIST)